1. CarsonDD, BagchiI, DeySK, EndersAC, FazleabasAT, et al. (2000) Embryo implantation. Dev Biol 223: 217–237.
2. NorwitzER, SchustDJ, FisherSJ (2001) Implantation and the survival of early pregnancy. N Engl J Med 345: 1400–1408.
3. WilcoxAJ, BairdDD, WeinbergCR (1999) Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340: 1796–1799.
4. ChaJ, SunX, DeySK (2012) Mechanisms of implantation: strategies for successful pregnancy. Nat Med 18: 1754–1767.
5. DiedrichK, FauserBC, DevroeyP, GriesingerG (2007) Evian Annual Reproduction Workshop G (2007) The role of the endometrium and embryo in human implantation. Hum Reprod Update 13: 365–377.
6. StrowitzkiT, GermeyerA, PopoviciR, von WolffM (2006) The human endometrium as a fertility-determining factor. Hum Reprod Update 12: 617–630.
7. DasSK (2009) Cell cycle regulatory control for uterine stromal cell decidualization in implantation. Reproduction 137: 889–899.
8. SrogaJM, MaX, DasSK (2012) Developmental regulation of decidual cell polyploidy at the site of implantation. Front Biosci (Schol Ed) 4: 1475–1486.
9. FinnCA, MartinL (1972) Endocrine control of the timing of endometrial sensitivity to a decidual stimulus. Biol Reprod 7: 82–86.
10. XuJ, WuRC, O'MalleyBW (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615–630.
11. MukherjeeA, AmatoP, AllredDC, DeMayoFJ, LydonJP (2007) Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human. Nucl Recept Signal 5: e011.
12. MukherjeeA, SoyalSM, Fernandez-ValdiviaR, GehinM, ChambonP, et al. (2006) Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol Cell Biol 26: 6571–6583.
13. GregoryCW, WilsonEM, ApparaoKB, LiningerRA, MeyerWR, et al. (2002) Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 87: 2960–2966.
14. CondonJC, JeyasuriaP, FaustJM, WilsonJW, MendelsonCR (2003) A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 100: 9518–9523.
15. KonnoT, GrahamAR, RempelLA, Ho-ChenJK, AlamSM, et al. (2010) Subfertility linked to combined luteal insufficiency and uterine progesterone resistance. Endocrinology 151: 4537–4550.
16. YinP, LinZ, ReierstadS, WuJ, IshikawaH, et al. (2010) Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res 70: 1722–1730.
17. ChopraAR, KommaganiR, SahaP, LouetJF, SalazarC, et al. (2011) Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab 13: 35–43.
18. ChopraAR, LouetJF, SahaP, AnJ, DemayoF, et al. (2008) Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322: 1395–1399.
19. YorkB, O'MalleyBW (2010) Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem 285: 38743–38750.
20. TongW, PollardJW (1999) Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19: 2251–2264.
21. FrancoHL, DaiD, LeeKY, RubelCA, RoopD, et al. (2011) WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J 25: 1176–1187.
22. HuyenDV, BanyBM (2011) Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization. Reproduction 142: 353–368.
23. LeeKY, JeongJW, WangJ, MaL, MartinJF, et al. (2007) Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27: 5468–5478.
24. LiQ, KannanA, DeMayoFJ, LydonJP, CookePS, et al. (2011) The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science 331: 912–916.
25. BrosensJJ, HayashiN, WhiteJO (1999) Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology 140: 4809–4820.
26. BrosensJJ, TakedaS, AcevedoCH, LewisMP, KirbyPL, et al. (1996) Human endometrial fibroblasts immortalized by simian virus 40 large T antigen differentiate in response to a decidualization stimulus. Endocrinology 137: 2225–2231.
27. DeBerardinisRJ, LumJJ, HatzivassiliouG, ThompsonCB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11–20.
28. LuntSY, Vander HeidenMG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441–464.
29. Vander HeidenMG, CantleyLC, ThompsonCB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029–1033.
30. Vander HeidenMG, LuntSY, DaytonTL, FiskeBP, IsraelsenWJ, et al. (2011) Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol 76: 325–334.
31. MetalloCM, Vander HeidenMG (2013) Understanding metabolic regulation and its influence on cell physiology. Mol Cell 49: 388–398.
32. YorkB, SagenJV, TsimelzonA, LouetJF, ChopraAR, et al. (2013) Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Mol Endocrinol 27: 366–380.
33. LouetJF, ChopraAR, SagenJV, AnJ, YorkB, et al. (2010) The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab 12: 606–618.
34. FrolovaAI, MoleyKH (2011) Quantitative analysis of glucose transporter mRNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology 152: 2123–2128.
35. FrolovaAI, O'NeillK, MoleyKH (2011) Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation. Mol Endocrinol 25: 1444–1455.
36. HacklH (1973) Metabolism of glucose in the human endometrium with special reference to fertility and contraception. Acta Obstet Gynecol Scand 52: 135–140.
37. von WolffM, UrselS, HahnU, SteldingerR, StrowitzkiT (2003) Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 88: 3885–3892.
38. YalcinA, TelangS, ClemB, ChesneyJ (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86: 174–179.
39. WuM, NeilsonA, SwiftAL, MoranR, TamagnineJ, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125–136.
40. ClemB, TelangS, ClemA, YalcinA, MeierJ, et al. (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110–120.
41. ChesneyJ (2006) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 9: 535–539.
42. ChesneyJ, TelangS, YalcinA, ClemA, WallisN, et al. (2005) Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality. Biochem Biophys Res Commun 331: 139–146.
43. GalassiL (1968) Autoradiographic study of the decidual cell reaction in the rat. Dev Biol 17: 75–84.
44. GermeyerA, von WolffM, JauckusJ, StrowitzkiT, SharmaT, et al. (2010) Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures–a pilot study. Reprod Biol Endocrinol 8: 67.
45. MoultonBC, BarkerKL (1974) Effects of 8-azaguanine on the induction of uterine glucose-6-phosphate dehydrogenase activity by estradiol or NADP plus. Proc Soc Exp Biol Med 146: 742–746.
46. SuraniMA, HealdPJ (1971) Changes in enzymes of carbohydrate metabolism in rat uterus during early pregnancy. Acta Endocrinol (Copenh) 68: 805–816.
47. SuraniMA, HealdPJ (1971) The metabolism of glucose by rat uterus tissue in early pregnancy. Acta Endocrinol (Copenh) 66: 16–24.
48. HamiltonJA, CallaghanMJ, SutherlandRL, WattsCKW (1997) Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase. Mol Endo 11: 490–502.
49. NovellasdemuntL, ObachM, Millan-ArinoL, ManzanoA, VenturaF, et al. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells. Biochem J 442: 345–356.
50. AtsumiT, ChesneyJ, MetzC, LengL, DonnellyS, et al. (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881–5887.
51. MarottaLL, AlmendroV, MarusykA, ShipitsinM, SchemmeJ, et al. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(−) stem cell-like breast cancer cells in human tumors. J Clin Invest 121: 2723–2735.
52. MinchenkoA, LeshchinskyI, OpentanovaI, SangN, SrinivasV, et al. (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277: 6183–6187.
53. ReddyMM, FernandesMS, DeshpandeA, WeisbergE, InguilizianHV, et al. (2012) The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity. Leukemia 26: 481–489.
54. Rodriguez-RodriguezP, FernandezE, AlmeidaA, BolanosJP (2012) Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ 19: 1582–1589.
55. TelangS, YalcinA, ClemAL, BucalaR, LaneAN, et al. (2006) Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 25: 7225–7234.
56. FukasawaM, TsuchiyaT, TakayamaE, ShinomiyaN, UyedaK, et al. (2004) Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biochem 136: 273–277.
57. SoyalSM, MukherjeeA, LeeKY, LiJ, LiH, et al. (2005) Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41: 58–66.
58. GehinM, MarkM, DennefeldC, DierichA, GronemeyerH, et al. (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22: 5923–5937.
59. WMA Declaration of Helsinki Serves as Guide to Physicians. Calif Med 105: 149–150.
60. KhokharSK, KommaganiR, KadakiaMP (2008) Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes. Cell Res 18: 1061–1073.
61. MukherjeeA, SoyalSM, LiJ, YingY, SzwarcMM, et al. (2011) A mouse transgenic approach to induce beta-catenin signaling in a temporally controlled manner. Transgenic Res 20: 827–840.
62. PutluriN, ShojaieA, VasuVT, NalluriS, VareedSK, et al. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells. PLoS One 6: e21417.